COVID-19 Impact on STD Diagnostics Market, Global Research Reports 2020-2021
This report covers market size and forecasts of STD Diagnostics, including the following market information:
Major competitors identified in this market include Abbott, ADI/American Diagnostica, Agilent Technologies, Alere/Biosite/Inverness, Axis-Shield, Beckman Coulter/Danaher, Becton Dickinson, Bio/Data, Decode Genetics, Diadexus, Diagnocure, Diagnostica Stago/Trinity Biotech, Diamedix, Polymedco, Qiagen, Roche, SDIX, Sequenom, Siemens, Sienco, Sysmex, Takara Bio, ThermoFisher, Tosoh, Wako, Zycare/Alere, etc.
Based on the Region:
- Global STD Diagnostics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global STD Diagnostics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global STD Diagnostics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global STD Diagnostics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Abbott, ADI/American Diagnostica, Agilent Technologies, Alere/Biosite/Inverness, Axis-Shield, Beckman Coulter/Danaher, Becton Dickinson, Bio/Data, Decode Genetics, Diadexus, Diagnocure, Diagnostica Stago/Trinity Biotech, Diamedix, Polymedco, Qiagen, Roche, SDIX, Sequenom, Siemens, Sienco, Sysmex, Takara Bio, ThermoFisher, Tosoh, Wako, Zycare/Alere, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Chlamydia Testing
- Syphilis Testing
- Gonorrhea Testing
- Herpes Simplex Virus Testing
- Human Papilloma Virus Testing
- Human Immunodeficiency Virus Testing
- Chancroid Testing
- Laboratory Testing
- Point of Care Testing
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on STD Diagnostics Industry
1.7 COVID-19 Impact: STD Diagnostics Market Trends
2 GLOBAL STD DIAGNOSTICS QUARTERLY MARKET SIZE ANALYSIS
2.1 STD Diagnostics Business Impact Assessment - COVID-19
2.1.1 Global STD Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global STD Diagnostics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global STD Diagnostics Quarterly Market Size, 2019 VS 2020
3.2 By Players, STD Diagnostics Headquarters and Area Served
3.3 Date of Key Players Enter into STD Diagnostics Market
3.4 Key Players STD Diagnostics Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON STD DIAGNOSTICS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Chlamydia Testing
1.4.2 Syphilis Testing
1.4.3 Gonorrhea Testing
1.4.4 Herpes Simplex Virus Testing
1.4.5 Human Papilloma Virus Testing
1.4.6 Human Immunodeficiency Virus Testing
1.4.7 Chancroid Testing
4.2 By Type, Global STD Diagnostics Market Size, 2019-2021
5 IMPACT OF COVID-19 ON STD DIAGNOSTICS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Laboratory Testing
5.5.2 Point of Care Testing
5.2 By Application, Global STD Diagnostics Market Size, 2019-2021
5.2.1 By Application, Global STD Diagnostics Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Abbott
7.1.1 Abbott Business Overview
7.1.2 Abbott STD Diagnostics Quarterly Revenue, 2020
7.1.3 Abbott STD Diagnostics Product Introduction
7.1.4 Abbott Response to COVID-19 and Related Developments
7.2 ADI/American Diagnostica
7.2.1 ADI/American Diagnostica Business Overview
7.2.2 ADI/American Diagnostica STD Diagnostics Quarterly Revenue, 2020
7.2.3 ADI/American Diagnostica STD Diagnostics Product Introduction
7.2.4 ADI/American Diagnostica Response to COVID-19 and Related Developments
7.3 Agilent Technologies
7.3.1 Agilent Technologies Business Overview
7.3.2 Agilent Technologies STD Diagnostics Quarterly Revenue, 2020
7.3.3 Agilent Technologies STD Diagnostics Product Introduction
7.3.4 Agilent Technologies Response to COVID-19 and Related Developments
7.4 Alere/Biosite/Inverness
7.4.1 Alere/Biosite/Inverness Business Overview
7.4.2 Alere/Biosite/Inverness STD Diagnostics Quarterly Revenue, 2020
7.4.3 Alere/Biosite/Inverness STD Diagnostics Product Introduction
7.4.4 Alere/Biosite/Inverness Response to COVID-19 and Related Developments
7.5 Axis-Shield
7.5.1 Axis-Shield Business Overview
7.5.2 Axis-Shield STD Diagnostics Quarterly Revenue, 2020
7.5.3 Axis-Shield STD Diagnostics Product Introduction
7.5.4 Axis-Shield Response to COVID-19 and Related Developments
7.6 Beckman Coulter/Danaher
7.6.1 Beckman Coulter/Danaher Business Overview
7.6.2 Beckman Coulter/Danaher STD Diagnostics Quarterly Revenue, 2020
7.6.3 Beckman Coulter/Danaher STD Diagnostics Product Introduction
7.6.4 Beckman Coulter/Danaher Response to COVID-19 and Related Developments
7.7 Becton Dickinson
7.7.1 Becton Dickinson Business Overview
7.7.2 Becton Dickinson STD Diagnostics Quarterly Revenue, 2020
7.7.3 Becton Dickinson STD Diagnostics Product Introduction
7.7.4 Becton Dickinson Response to COVID-19 and Related Developments
7.8 Bio/Data
7.8.1 Bio/Data Business Overview
7.8.2 Bio/Data STD Diagnostics Quarterly Revenue, 2020
7.8.3 Bio/Data STD Diagnostics Product Introduction
7.8.4 Bio/Data Response to COVID-19 and Related Developments
7.9 Decode Genetics
7.9.1 Decode Genetics Business Overview
7.9.2 Decode Genetics STD Diagnostics Quarterly Revenue, 2020
7.9.3 Decode Genetics STD Diagnostics Product Introduction
7.9.4 Decode Genetics Response to COVID-19 and Related Developments
7.10 Diadexus
7.10.1 Diadexus Business Overview
7.10.2 Diadexus STD Diagnostics Quarterly Revenue, 2020
7.10.3 Diadexus STD Diagnostics Product Introduction
7.10.4 Diadexus Response to COVID-19 and Related Developments
7.11 Diagnocure
7.11.1 Diagnocure Business Overview
7.11.2 Diagnocure STD Diagnostics Quarterly Revenue, 2020
7.11.3 Diagnocure STD Diagnostics Product Introduction
7.11.4 Diagnocure Response to COVID-19 and Related Developments
7.12 Diagnostica Stago/Trinity Biotech
7.12.1 Diagnostica Stago/Trinity Biotech Business Overview
7.12.2 Diagnostica Stago/Trinity Biotech STD Diagnostics Quarterly Revenue, 2020
7.12.3 Diagnostica Stago/Trinity Biotech STD Diagnostics Product Introduction
7.12.4 Diagnostica Stago/Trinity Biotech Response to COVID-19 and Related Developments
7.13 Diamedix
7.13.1 Diamedix Business Overview
7.13.2 Diamedix STD Diagnostics Quarterly Revenue, 2020
7.13.3 Diamedix STD Diagnostics Product Introduction
7.13.4 Diamedix Response to COVID-19 and Related Developments
7.14 Polymedco
7.14.1 Polymedco Business Overview
7.14.2 Polymedco STD Diagnostics Quarterly Revenue, 2020
7.14.3 Polymedco STD Diagnostics Product Introduction
7.14.4 Polymedco Response to COVID-19 and Related Developments
7.15 Qiagen
7.15.1 Qiagen Business Overview
7.15.2 Qiagen STD Diagnostics Quarterly Revenue, 2020
7.15.3 Qiagen STD Diagnostics Product Introduction
7.15.4 Qiagen Response to COVID-19 and Related Developments
7.16 Roche
7.16.1 Roche Business Overview
7.16.2 Roche STD Diagnostics Quarterly Revenue, 2020
7.16.3 Roche STD Diagnostics Product Introduction
7.16.4 Roche Response to COVID-19 and Related Developments
7.17 SDIX
7.17.1 SDIX Business Overview
7.17.2 SDIX STD Diagnostics Quarterly Revenue, 2020
7.17.3 SDIX STD Diagnostics Product Introduction
7.17.4 SDIX Response to COVID-19 and Related Developments
7.18 Sequenom
7.18.1 Sequenom Business Overview
7.18.2 Sequenom STD Diagnostics Quarterly Revenue, 2020
7.18.3 Sequenom STD Diagnostics Product Introduction
7.18.4 Sequenom Response to COVID-19 and Related Developments
7.19 Siemens
7.19.1 Siemens Business Overview
7.19.2 Siemens STD Diagnostics Quarterly Revenue, 2020
7.19.3 Siemens STD Diagnostics Product Introduction
7.19.4 Siemens Response to COVID-19 and Related Developments
7.20 Sienco
7.20.1 Sienco Business Overview
7.20.2 Sienco STD Diagnostics Quarterly Revenue, 2020
7.20.3 Sienco STD Diagnostics Product Introduction
7.20.4 Sienco Response to COVID-19 and Related Developments
7.21 Sysmex
7.21.1 Sysmex Business Overview
7.21.2 Sysmex STD Diagnostics Quarterly Revenue, 2020
7.21.3 Sysmex STD Diagnostics Product Introduction
7.21.4 Sysmex Response to COVID-19 and Related Developments
7.22 Takara Bio
7.22.1 Takara Bio Business Overview
7.22.2 Takara Bio STD Diagnostics Quarterly Revenue, 2020
7.22.3 Takara Bio STD Diagnostics Product Introduction
7.22.4 Takara Bio Response to COVID-19 and Related Developments
7.23 ThermoFisher
7.23.1 ThermoFisher Business Overview
7.23.2 ThermoFisher STD Diagnostics Quarterly Revenue, 2020
7.23.3 ThermoFisher STD Diagnostics Product Introduction
7.23.4 ThermoFisher Response to COVID-19 and Related Developments
7.24 Tosoh
7.24.1 Tosoh Business Overview
7.24.2 Tosoh STD Diagnostics Quarterly Revenue, 2020
7.24.3 Tosoh STD Diagnostics Product Introduction
7.24.4 Tosoh Response to COVID-19 and Related Developments
7.25 Wako
7.25.1 Wako Business Overview
7.25.2 Wako STD Diagnostics Quarterly Revenue, 2020
7.25.3 Wako STD Diagnostics Product Introduction
7.25.4 Wako Response to COVID-19 and Related Developments
7.26 Zycare/Alere
7.26.1 Zycare/Alere Business Overview
7.26.2 Zycare/Alere STD Diagnostics Quarterly Revenue, 2020
7.26.3 Zycare/Alere STD Diagnostics Product Introduction
7.26.4 Zycare/Alere Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on STD Diagnostics Industry
1.7 COVID-19 Impact: STD Diagnostics Market Trends
2 GLOBAL STD DIAGNOSTICS QUARTERLY MARKET SIZE ANALYSIS
2.1 STD Diagnostics Business Impact Assessment - COVID-19
2.1.1 Global STD Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global STD Diagnostics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global STD Diagnostics Quarterly Market Size, 2019 VS 2020
3.2 By Players, STD Diagnostics Headquarters and Area Served
3.3 Date of Key Players Enter into STD Diagnostics Market
3.4 Key Players STD Diagnostics Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON STD DIAGNOSTICS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Chlamydia Testing
1.4.2 Syphilis Testing
1.4.3 Gonorrhea Testing
1.4.4 Herpes Simplex Virus Testing
1.4.5 Human Papilloma Virus Testing
1.4.6 Human Immunodeficiency Virus Testing
1.4.7 Chancroid Testing
4.2 By Type, Global STD Diagnostics Market Size, 2019-2021
5 IMPACT OF COVID-19 ON STD DIAGNOSTICS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Laboratory Testing
5.5.2 Point of Care Testing
5.2 By Application, Global STD Diagnostics Market Size, 2019-2021
5.2.1 By Application, Global STD Diagnostics Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Abbott
7.1.1 Abbott Business Overview
7.1.2 Abbott STD Diagnostics Quarterly Revenue, 2020
7.1.3 Abbott STD Diagnostics Product Introduction
7.1.4 Abbott Response to COVID-19 and Related Developments
7.2 ADI/American Diagnostica
7.2.1 ADI/American Diagnostica Business Overview
7.2.2 ADI/American Diagnostica STD Diagnostics Quarterly Revenue, 2020
7.2.3 ADI/American Diagnostica STD Diagnostics Product Introduction
7.2.4 ADI/American Diagnostica Response to COVID-19 and Related Developments
7.3 Agilent Technologies
7.3.1 Agilent Technologies Business Overview
7.3.2 Agilent Technologies STD Diagnostics Quarterly Revenue, 2020
7.3.3 Agilent Technologies STD Diagnostics Product Introduction
7.3.4 Agilent Technologies Response to COVID-19 and Related Developments
7.4 Alere/Biosite/Inverness
7.4.1 Alere/Biosite/Inverness Business Overview
7.4.2 Alere/Biosite/Inverness STD Diagnostics Quarterly Revenue, 2020
7.4.3 Alere/Biosite/Inverness STD Diagnostics Product Introduction
7.4.4 Alere/Biosite/Inverness Response to COVID-19 and Related Developments
7.5 Axis-Shield
7.5.1 Axis-Shield Business Overview
7.5.2 Axis-Shield STD Diagnostics Quarterly Revenue, 2020
7.5.3 Axis-Shield STD Diagnostics Product Introduction
7.5.4 Axis-Shield Response to COVID-19 and Related Developments
7.6 Beckman Coulter/Danaher
7.6.1 Beckman Coulter/Danaher Business Overview
7.6.2 Beckman Coulter/Danaher STD Diagnostics Quarterly Revenue, 2020
7.6.3 Beckman Coulter/Danaher STD Diagnostics Product Introduction
7.6.4 Beckman Coulter/Danaher Response to COVID-19 and Related Developments
7.7 Becton Dickinson
7.7.1 Becton Dickinson Business Overview
7.7.2 Becton Dickinson STD Diagnostics Quarterly Revenue, 2020
7.7.3 Becton Dickinson STD Diagnostics Product Introduction
7.7.4 Becton Dickinson Response to COVID-19 and Related Developments
7.8 Bio/Data
7.8.1 Bio/Data Business Overview
7.8.2 Bio/Data STD Diagnostics Quarterly Revenue, 2020
7.8.3 Bio/Data STD Diagnostics Product Introduction
7.8.4 Bio/Data Response to COVID-19 and Related Developments
7.9 Decode Genetics
7.9.1 Decode Genetics Business Overview
7.9.2 Decode Genetics STD Diagnostics Quarterly Revenue, 2020
7.9.3 Decode Genetics STD Diagnostics Product Introduction
7.9.4 Decode Genetics Response to COVID-19 and Related Developments
7.10 Diadexus
7.10.1 Diadexus Business Overview
7.10.2 Diadexus STD Diagnostics Quarterly Revenue, 2020
7.10.3 Diadexus STD Diagnostics Product Introduction
7.10.4 Diadexus Response to COVID-19 and Related Developments
7.11 Diagnocure
7.11.1 Diagnocure Business Overview
7.11.2 Diagnocure STD Diagnostics Quarterly Revenue, 2020
7.11.3 Diagnocure STD Diagnostics Product Introduction
7.11.4 Diagnocure Response to COVID-19 and Related Developments
7.12 Diagnostica Stago/Trinity Biotech
7.12.1 Diagnostica Stago/Trinity Biotech Business Overview
7.12.2 Diagnostica Stago/Trinity Biotech STD Diagnostics Quarterly Revenue, 2020
7.12.3 Diagnostica Stago/Trinity Biotech STD Diagnostics Product Introduction
7.12.4 Diagnostica Stago/Trinity Biotech Response to COVID-19 and Related Developments
7.13 Diamedix
7.13.1 Diamedix Business Overview
7.13.2 Diamedix STD Diagnostics Quarterly Revenue, 2020
7.13.3 Diamedix STD Diagnostics Product Introduction
7.13.4 Diamedix Response to COVID-19 and Related Developments
7.14 Polymedco
7.14.1 Polymedco Business Overview
7.14.2 Polymedco STD Diagnostics Quarterly Revenue, 2020
7.14.3 Polymedco STD Diagnostics Product Introduction
7.14.4 Polymedco Response to COVID-19 and Related Developments
7.15 Qiagen
7.15.1 Qiagen Business Overview
7.15.2 Qiagen STD Diagnostics Quarterly Revenue, 2020
7.15.3 Qiagen STD Diagnostics Product Introduction
7.15.4 Qiagen Response to COVID-19 and Related Developments
7.16 Roche
7.16.1 Roche Business Overview
7.16.2 Roche STD Diagnostics Quarterly Revenue, 2020
7.16.3 Roche STD Diagnostics Product Introduction
7.16.4 Roche Response to COVID-19 and Related Developments
7.17 SDIX
7.17.1 SDIX Business Overview
7.17.2 SDIX STD Diagnostics Quarterly Revenue, 2020
7.17.3 SDIX STD Diagnostics Product Introduction
7.17.4 SDIX Response to COVID-19 and Related Developments
7.18 Sequenom
7.18.1 Sequenom Business Overview
7.18.2 Sequenom STD Diagnostics Quarterly Revenue, 2020
7.18.3 Sequenom STD Diagnostics Product Introduction
7.18.4 Sequenom Response to COVID-19 and Related Developments
7.19 Siemens
7.19.1 Siemens Business Overview
7.19.2 Siemens STD Diagnostics Quarterly Revenue, 2020
7.19.3 Siemens STD Diagnostics Product Introduction
7.19.4 Siemens Response to COVID-19 and Related Developments
7.20 Sienco
7.20.1 Sienco Business Overview
7.20.2 Sienco STD Diagnostics Quarterly Revenue, 2020
7.20.3 Sienco STD Diagnostics Product Introduction
7.20.4 Sienco Response to COVID-19 and Related Developments
7.21 Sysmex
7.21.1 Sysmex Business Overview
7.21.2 Sysmex STD Diagnostics Quarterly Revenue, 2020
7.21.3 Sysmex STD Diagnostics Product Introduction
7.21.4 Sysmex Response to COVID-19 and Related Developments
7.22 Takara Bio
7.22.1 Takara Bio Business Overview
7.22.2 Takara Bio STD Diagnostics Quarterly Revenue, 2020
7.22.3 Takara Bio STD Diagnostics Product Introduction
7.22.4 Takara Bio Response to COVID-19 and Related Developments
7.23 ThermoFisher
7.23.1 ThermoFisher Business Overview
7.23.2 ThermoFisher STD Diagnostics Quarterly Revenue, 2020
7.23.3 ThermoFisher STD Diagnostics Product Introduction
7.23.4 ThermoFisher Response to COVID-19 and Related Developments
7.24 Tosoh
7.24.1 Tosoh Business Overview
7.24.2 Tosoh STD Diagnostics Quarterly Revenue, 2020
7.24.3 Tosoh STD Diagnostics Product Introduction
7.24.4 Tosoh Response to COVID-19 and Related Developments
7.25 Wako
7.25.1 Wako Business Overview
7.25.2 Wako STD Diagnostics Quarterly Revenue, 2020
7.25.3 Wako STD Diagnostics Product Introduction
7.25.4 Wako Response to COVID-19 and Related Developments
7.26 Zycare/Alere
7.26.1 Zycare/Alere Business Overview
7.26.2 Zycare/Alere STD Diagnostics Quarterly Revenue, 2020
7.26.3 Zycare/Alere STD Diagnostics Product Introduction
7.26.4 Zycare/Alere Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on STD Diagnostics Assessment
Table 9. COVID-19 Impact: STD Diagnostics Market Trends
Table 10. COVID-19 Impact Global STD Diagnostics Market Size
Table 11. Global STD Diagnostics Quarterly Market Size, 2020 (US$ Million)
Table 12. Global STD Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global STD Diagnostics Market Growth Drivers
Table 14. Global STD Diagnostics Market Restraints
Table 15. Global STD Diagnostics Market Opportunities
Table 16. Global STD Diagnostics Market Challenges
Table 17. By Players, STD Diagnostics Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, STD Diagnostics Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key STD Diagnostics Players Headquarters and Area Served
Table 20. Date of Key Players Enter into STD Diagnostics Market
Table 21. Key Players STD Diagnostics Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global STD Diagnostics Market Size 2019-2021, (US$ Million)
Table 24. Global STD Diagnostics Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global STD Diagnostics Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 57. Abbott Business Overview
Table 58. Abbott STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Abbott STD Diagnostics Product
Table 60. Abbott Response to COVID-19 and Related Developments
Table 61. ADI/American Diagnostica Business Overview
Table 62. ADI/American Diagnostica STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. ADI/American Diagnostica STD Diagnostics Product
Table 64. ADI/American Diagnostica Response to COVID-19 and Related Developments
Table 65. Agilent Technologies Business Overview
Table 66. Agilent Technologies STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Agilent Technologies STD Diagnostics Product
Table 68. Agilent Technologies Response to COVID-19 and Related Developments
Table 69. Alere/Biosite/Inverness Business Overview
Table 70. Alere/Biosite/Inverness STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Alere/Biosite/Inverness STD Diagnostics Product
Table 72. Alere/Biosite/Inverness Response to COVID-19 and Related Developments
Table 73. Axis-Shield Business Overview
Table 74. Axis-Shield STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Axis-Shield STD Diagnostics Product
Table 76. Axis-Shield Response to COVID-19 and Related Developments
Table 77. Beckman Coulter/Danaher Business Overview
Table 78. Beckman Coulter/Danaher STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Beckman Coulter/Danaher STD Diagnostics Product
Table 80. Beckman Coulter/Danaher Response to COVID-19 and Related Developments
Table 81. Becton Dickinson Business Overview
Table 82. Becton Dickinson STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Becton Dickinson STD Diagnostics Product
Table 84. Becton Dickinson Response to COVID-19 and Related Developments
Table 85. Bio/Data Business Overview
Table 86. Bio/Data STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Bio/Data STD Diagnostics Product
Table 88. Bio/Data Response to COVID-19 and Related Developments
Table 89. Decode Genetics Business Overview
Table 90. Decode Genetics STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Decode Genetics STD Diagnostics Product
Table 92. Decode Genetics Response to COVID-19 and Related Developments
Table 93. Diadexus Business Overview
Table 94. Diadexus STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Diadexus STD Diagnostics Product
Table 96. Diadexus Response to COVID-19 and Related Developments
Table 97. Diagnocure Business Overview
Table 98. Diagnocure STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Diagnocure STD Diagnostics Product
Table 100. Diagnocure Response to COVID-19 and Related Developments
Table 101. Diagnostica Stago/Trinity Biotech Business Overview
Table 102. Diagnostica Stago/Trinity Biotech STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Diagnostica Stago/Trinity Biotech STD Diagnostics Product
Table 104. Diagnostica Stago/Trinity Biotech Response to COVID-19 and Related Developments
Table 105. Diamedix Business Overview
Table 106. Diamedix STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. Diamedix STD Diagnostics Product
Table 108. Diamedix Response to COVID-19 and Related Developments
Table 109. Polymedco Business Overview
Table 110. Polymedco STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 111. Polymedco STD Diagnostics Product
Table 112. Polymedco Response to COVID-19 and Related Developments
Table 113. Qiagen Business Overview
Table 114. Qiagen STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 115. Qiagen STD Diagnostics Product
Table 116. Qiagen Response to COVID-19 and Related Developments
Table 117. Roche Business Overview
Table 118. Roche STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 119. Roche STD Diagnostics Product
Table 120. Roche Response to COVID-19 and Related Developments
Table 121. SDIX Business Overview
Table 122. SDIX STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 123. SDIX STD Diagnostics Product
Table 124. SDIX Response to COVID-19 and Related Developments
Table 125. Sequenom Business Overview
Table 126. Sequenom STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 127. Sequenom STD Diagnostics Product
Table 128. Sequenom Response to COVID-19 and Related Developments
Table 129. Siemens Business Overview
Table 130. Siemens STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 131. Siemens STD Diagnostics Product
Table 132. Siemens Response to COVID-19 and Related Developments
Table 133. Sienco Business Overview
Table 134. Sienco STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 135. Sienco STD Diagnostics Product
Table 136. Sienco Response to COVID-19 and Related Developments
Table 137. Sysmex Business Overview
Table 138. Sysmex STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 139. Sysmex STD Diagnostics Product
Table 140. Sysmex Response to COVID-19 and Related Developments
Table 141. Takara Bio Business Overview
Table 142. Takara Bio STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 143. Takara Bio STD Diagnostics Product
Table 144. Takara Bio Response to COVID-19 and Related Developments
Table 145. ThermoFisher Business Overview
Table 146. ThermoFisher STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 147. ThermoFisher STD Diagnostics Product
Table 148. ThermoFisher Response to COVID-19 and Related Developments
Table 149. Tosoh Business Overview
Table 150. Tosoh STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 151. Tosoh STD Diagnostics Product
Table 152. Tosoh Response to COVID-19 and Related Developments
Table 153. Wako Business Overview
Table 154. Wako STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 155. Wako STD Diagnostics Product
Table 156. Wako Response to COVID-19 and Related Developments
Table 157. Zycare/Alere Business Overview
Table 158. Zycare/Alere STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 159. Zycare/Alere STD Diagnostics Product
Table 160. Zycare/Alere Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on STD Diagnostics Assessment
Table 9. COVID-19 Impact: STD Diagnostics Market Trends
Table 10. COVID-19 Impact Global STD Diagnostics Market Size
Table 11. Global STD Diagnostics Quarterly Market Size, 2020 (US$ Million)
Table 12. Global STD Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global STD Diagnostics Market Growth Drivers
Table 14. Global STD Diagnostics Market Restraints
Table 15. Global STD Diagnostics Market Opportunities
Table 16. Global STD Diagnostics Market Challenges
Table 17. By Players, STD Diagnostics Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, STD Diagnostics Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key STD Diagnostics Players Headquarters and Area Served
Table 20. Date of Key Players Enter into STD Diagnostics Market
Table 21. Key Players STD Diagnostics Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global STD Diagnostics Market Size 2019-2021, (US$ Million)
Table 24. Global STD Diagnostics Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global STD Diagnostics Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa STD Diagnostics Market Size, 2019-2021 (US$ Million)
Table 57. Abbott Business Overview
Table 58. Abbott STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Abbott STD Diagnostics Product
Table 60. Abbott Response to COVID-19 and Related Developments
Table 61. ADI/American Diagnostica Business Overview
Table 62. ADI/American Diagnostica STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. ADI/American Diagnostica STD Diagnostics Product
Table 64. ADI/American Diagnostica Response to COVID-19 and Related Developments
Table 65. Agilent Technologies Business Overview
Table 66. Agilent Technologies STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Agilent Technologies STD Diagnostics Product
Table 68. Agilent Technologies Response to COVID-19 and Related Developments
Table 69. Alere/Biosite/Inverness Business Overview
Table 70. Alere/Biosite/Inverness STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Alere/Biosite/Inverness STD Diagnostics Product
Table 72. Alere/Biosite/Inverness Response to COVID-19 and Related Developments
Table 73. Axis-Shield Business Overview
Table 74. Axis-Shield STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Axis-Shield STD Diagnostics Product
Table 76. Axis-Shield Response to COVID-19 and Related Developments
Table 77. Beckman Coulter/Danaher Business Overview
Table 78. Beckman Coulter/Danaher STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Beckman Coulter/Danaher STD Diagnostics Product
Table 80. Beckman Coulter/Danaher Response to COVID-19 and Related Developments
Table 81. Becton Dickinson Business Overview
Table 82. Becton Dickinson STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Becton Dickinson STD Diagnostics Product
Table 84. Becton Dickinson Response to COVID-19 and Related Developments
Table 85. Bio/Data Business Overview
Table 86. Bio/Data STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Bio/Data STD Diagnostics Product
Table 88. Bio/Data Response to COVID-19 and Related Developments
Table 89. Decode Genetics Business Overview
Table 90. Decode Genetics STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Decode Genetics STD Diagnostics Product
Table 92. Decode Genetics Response to COVID-19 and Related Developments
Table 93. Diadexus Business Overview
Table 94. Diadexus STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Diadexus STD Diagnostics Product
Table 96. Diadexus Response to COVID-19 and Related Developments
Table 97. Diagnocure Business Overview
Table 98. Diagnocure STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Diagnocure STD Diagnostics Product
Table 100. Diagnocure Response to COVID-19 and Related Developments
Table 101. Diagnostica Stago/Trinity Biotech Business Overview
Table 102. Diagnostica Stago/Trinity Biotech STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Diagnostica Stago/Trinity Biotech STD Diagnostics Product
Table 104. Diagnostica Stago/Trinity Biotech Response to COVID-19 and Related Developments
Table 105. Diamedix Business Overview
Table 106. Diamedix STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. Diamedix STD Diagnostics Product
Table 108. Diamedix Response to COVID-19 and Related Developments
Table 109. Polymedco Business Overview
Table 110. Polymedco STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 111. Polymedco STD Diagnostics Product
Table 112. Polymedco Response to COVID-19 and Related Developments
Table 113. Qiagen Business Overview
Table 114. Qiagen STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 115. Qiagen STD Diagnostics Product
Table 116. Qiagen Response to COVID-19 and Related Developments
Table 117. Roche Business Overview
Table 118. Roche STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 119. Roche STD Diagnostics Product
Table 120. Roche Response to COVID-19 and Related Developments
Table 121. SDIX Business Overview
Table 122. SDIX STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 123. SDIX STD Diagnostics Product
Table 124. SDIX Response to COVID-19 and Related Developments
Table 125. Sequenom Business Overview
Table 126. Sequenom STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 127. Sequenom STD Diagnostics Product
Table 128. Sequenom Response to COVID-19 and Related Developments
Table 129. Siemens Business Overview
Table 130. Siemens STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 131. Siemens STD Diagnostics Product
Table 132. Siemens Response to COVID-19 and Related Developments
Table 133. Sienco Business Overview
Table 134. Sienco STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 135. Sienco STD Diagnostics Product
Table 136. Sienco Response to COVID-19 and Related Developments
Table 137. Sysmex Business Overview
Table 138. Sysmex STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 139. Sysmex STD Diagnostics Product
Table 140. Sysmex Response to COVID-19 and Related Developments
Table 141. Takara Bio Business Overview
Table 142. Takara Bio STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 143. Takara Bio STD Diagnostics Product
Table 144. Takara Bio Response to COVID-19 and Related Developments
Table 145. ThermoFisher Business Overview
Table 146. ThermoFisher STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 147. ThermoFisher STD Diagnostics Product
Table 148. ThermoFisher Response to COVID-19 and Related Developments
Table 149. Tosoh Business Overview
Table 150. Tosoh STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 151. Tosoh STD Diagnostics Product
Table 152. Tosoh Response to COVID-19 and Related Developments
Table 153. Wako Business Overview
Table 154. Wako STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 155. Wako STD Diagnostics Product
Table 156. Wako Response to COVID-19 and Related Developments
Table 157. Zycare/Alere Business Overview
Table 158. Zycare/Alere STD Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 159. Zycare/Alere STD Diagnostics Product
Table 160. Zycare/Alere Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. STD Diagnostics Product Picture
Figure 2. STD Diagnostics Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global STD Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global STD Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global STD Diagnostics Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global STD Diagnostics Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global STD Diagnostics Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global STD Diagnostics Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific STD Diagnostics Market Size Market Share, 2019-2021
Figure 1. STD Diagnostics Product Picture
Figure 2. STD Diagnostics Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global STD Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global STD Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global STD Diagnostics Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global STD Diagnostics Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global STD Diagnostics Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global STD Diagnostics Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific STD Diagnostics Market Size Market Share, 2019-2021
